International Journal of Pharmaceutical Sciences and Drug Analysis
  • Printed Journal
  • Refereed Journal
  • Peer Reviewed Journal

P-ISSN: 2788-9246, E-ISSN: 2788-9254
Printed Journal   |   Refereed Journal   |   Peer Reviewed Journal

2022, Vol. 2, Issue 1, Part A

Study on COVID-19 vaccinations

Author(s): Dr. Sudhir Kumar Rawat

Abstract: The period beginning in December 2019 will be remembered forever in human history as the victim of the unique COVID-19 pandemic. Causing distress to every country it touches, it has created damaging economic, political, social and health impacts that will leave behind everlasting scars. Despite the use of numerous strategies by governments around the world, just a few have succeeded. The new outbreak of COVID-19 has recently become a serious threat to the health of people around the 250 countries. SARS-CoV-2, a single-stranded positive-sense RNA virus that causes infection and respiratory failure and has killed thousands of people, is the causem of COVID-19. Vaccines are needed to protect the human race from COVID-19. Vaccines that induce large quantities of high-affinity virus-neutralized antibodies may optimally prevent infection and avoid unfavorable effects. Vaccination trials require precise clinical supervision, complemented with a detailed evaluation of safety and immune responses.

Pages: 24-29 | Views: 331 | Downloads: 122

Download Full Article: Click Here
How to cite this article:
Dr. Sudhir Kumar Rawat. Study on COVID-19 vaccinations. Int J Pharm Sci Drug Anal 2022;2(1):24-29.
International Journal of Pharmaceutical Sciences and Drug Analysis
Call for book chapter